WINDLAS BIOTECH
Back to Income Statement
|
WINDLAS BIOTECH Last 5 Year Consolidated Net Profit History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Consolidated Net Profit | ₹61 Cr | ₹58 Cr | ₹43 Cr | ₹38 Cr | ₹16 Cr |
What is the latest Consolidated Net Profit of WINDLAS BIOTECH ?
| Year | Consolidated Net Profit |
|---|---|
| Mar2025 | ₹61 Cr |
| Mar2024 | ₹58 Cr |
| Mar2023 | ₹43 Cr |
| Mar2022 | ₹38 Cr |
| Mar2021 | ₹16 Cr |
How is Consolidated Net Profit of WINDLAS BIOTECH Trending?
| Years | Consolidated Net Profit | % Change | |
|---|---|---|---|
| Mar2025 | ₹61 Cr | 4.82 | |
| Mar2024 | ₹58 Cr | 36.51 | |
| Mar2023 | ₹43 Cr | 11.91 | |
| Mar2022 | ₹38 Cr | 140.58 | |
| Mar2021 | ₹16 Cr | - | |
Compare Consolidated Net Profit of peers of WINDLAS BIOTECH
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| WINDLAS BIOTECH | ₹1,659.5 Cr | -0.9% | -1.6% | -21.3% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹386,329.0 Cr | -0.2% | -6.3% | -8.8% | Stock Analytics | |
| DIVIS LABORATORIES | ₹164,674.0 Cr | 3.3% | -3.4% | 4% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹133,891.0 Cr | -0.7% | 3.8% | 26.3% | Stock Analytics | |
| CIPLA | ₹107,292.0 Cr | -3% | -11.8% | -8.8% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹102,184.0 Cr | 6% | -3.5% | -4.3% | Stock Analytics | |
WINDLAS BIOTECH Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| WINDLAS BIOTECH | -0.9% |
-1.6% |
-21.3% |
| SENSEX | 0.2% |
-3.6% |
8.6% |
You may also like the below Video Courses